phentolamine has been researched along with 15-keto-13,14-dihydroprostaglandin e2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Axelrod, L; Cornelius, P | 1 |
1 other study(ies) available for phentolamine and 15-keto-13,14-dihydroprostaglandin e2
| Article | Year |
|---|---|
Plasma prostaglandin levels and circulating fuel levels in rats with diabetic ketoacidosis: effects of cyclooxygenase inhibitors and of alpha and beta adrenergic blockade.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Glucose; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Diabetic Ketoacidosis; Dinoprostone; Fatty Acids, Nonesterified; Indomethacin; Ketone Bodies; Male; Meclofenamic Acid; ortho-Aminobenzoates; Phentolamine; Propranolol; Prostaglandins; Prostaglandins E; Rats; Rats, Inbred Strains; Thromboxane B2 | 1984 |